Roche’s experimental multiple sclerosis (MS) drug fenebrutinib has reached a major milestone, meeting its main goal in one of two late-stage trials for relapsing MS. The treatment sharply reduced annualised relapse rates over 96 weeks compared with..
The U.S. Food and Drug Administration (FDA) has granted final approval to Alembic Pharmaceuticals Limited for its Abbreviated New Drug Application (ANDA) of Sumatriptan Injection which represents a major achievement for the company in the...
Glenmark Specialty S.A.,a subsidiary of Glenmark Pharmaceuticals Ltd. that is fully owned, announced that its innovative nasal spray for allergic rhinitis, Ryaltris Compound Nasal Spray (GSP 301 NS), has received approval from China
Marksans Pharma experienced an increase of 1.94%, reaching Rs 186.30, following the announcement that it received zero observations during a current Good Manufacturing Practice (cGMP) inspection conducted by the US Food and Drug Administration
Novo Nordisk India partners with Emcure Pharma to launch Poviztra, expanding access to semaglutide 2.4 mg for safe, effective weight loss across India.
The Johnson & Johnson's (J&J) CAPLYTA (lumateperone) product has been given a green light by the U.S. Food and Drug Administration (USFDA) to be used as adjunctive therapy with antidepressants for adult major depressive disorder
.png "Pfizer Beats Novo Nordisk in $10 Billion Metsera Deal")
Pfizer has clinched a major victory in the race for next-generation obesity treatments, signing a deal to acquire development-stage drugmaker Metsera Inc. after outbidding rival Novo Nordisk, the maker of Ozempic and Wegovy...
The transition from volume-led growth to value- and innovation-led expansion is currently the defining trend of the Indian pharmaceutical business
Lupin has unveiled an ambitious tactical plan aimed at accelerating its growth through a strong product pipeline, widened market reach, and improved financial health. The company's latest update emphasizes a tightly managed approach
The Indian Pharmacopoeia Commission (IPC) intends to work on monographs and quality standards of three important TB drugs, such as delamanid, pretomanid and a fixed-dose combination (FDC) of rifapentine and isoniazid...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")